201 related articles for article (PubMed ID: 31253403)
1. Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation.
Zhu Y; Hu Q; Li H
Biochem Biophys Res Commun; 2019 Aug; 516(3):784-789. PubMed ID: 31253403
[TBL] [Abstract][Full Text] [Related]
2. Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation.
Liu Q; Chen J; Fu B; Dai J; Zhao Y; Lai L
Biochem Biophys Res Commun; 2018 Jun; 501(2):556-562. PubMed ID: 29746868
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway.
Pan Q; Liu R; Banu H; Ma L; Li H
Biomed Pharmacother; 2018 Mar; 99():169-175. PubMed ID: 29331763
[TBL] [Abstract][Full Text] [Related]
4. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration.
Cushman I; Casey PJ
J Biol Chem; 2009 Oct; 284(41):27964-27973. PubMed ID: 19651782
[TBL] [Abstract][Full Text] [Related]
5. An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo.
Lau HY; Ramanujulu PM; Guo D; Yang T; Wirawan M; Casey PJ; Go ML; Wang M
Cancer Biol Ther; 2014 Sep; 15(9):1280-91. PubMed ID: 24971579
[TBL] [Abstract][Full Text] [Related]
6. Suppression of oncogenic protein translation via targeting eukaryotic translation initiation factor 4E overcomes chemo-resistance in nasopharyngeal carcinoma.
Xu M; Tao Z; Wang S; Jiang Y; Qu M
Biochem Biophys Res Commun; 2019 May; 512(4):902-907. PubMed ID: 30929914
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mitochondrial function by approved drugs overcomes nasopharyngeal carcinoma chemoresistance.
Zhang Y; Guo D; Zhu Y; Liu L
Anticancer Drugs; 2024 Apr; 35(4):317-324. PubMed ID: 38215016
[TBL] [Abstract][Full Text] [Related]
8. Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms.
Lau HY; Tang J; Casey PJ; Wang M
Oncogene; 2017 Jul; 36(27):3934-3942. PubMed ID: 28192404
[TBL] [Abstract][Full Text] [Related]
9. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells.
Wang M; Tan W; Zhou J; Leow J; Go M; Lee HS; Casey PJ
J Biol Chem; 2008 Jul; 283(27):18678-84. PubMed ID: 18434300
[TBL] [Abstract][Full Text] [Related]
10. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
[No Abstract] [Full Text] [Related]
11. Genetic and pharmacologic analyses of the role of Icmt in Ras membrane association and function.
Svensson AW; Casey PJ; Young SG; Bergo MO
Methods Enzymol; 2006; 407():144-59. PubMed ID: 16757321
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Isoprenylcysteine Carboxylmethyltransferase Induces Cell-Cycle Arrest and Apoptosis through p21 and p21-Regulated BNIP3 Induction in Pancreatic Cancer.
Manu KA; Chai TF; Teh JT; Zhu WL; Casey PJ; Wang M
Mol Cancer Ther; 2017 May; 16(5):914-923. PubMed ID: 28167504
[TBL] [Abstract][Full Text] [Related]
13. Enhancer remodeling activates NOTCH3 signaling to confer chemoresistance in advanced nasopharyngeal carcinoma.
Liu L; Deng P; Liu S; Hong JH; Xiao R; Guan P; Wang Y; Wang P; Gao J; Chen J; Sun Y; Chen J; Mai HQ; Tan J
Cell Death Dis; 2023 Aug; 14(8):513. PubMed ID: 37563118
[TBL] [Abstract][Full Text] [Related]
14. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells.
Winter-Vann AM; Baron RA; Wong W; dela Cruz J; York JD; Gooden DM; Bergo MO; Young SG; Toone EJ; Casey PJ
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4336-41. PubMed ID: 15784746
[TBL] [Abstract][Full Text] [Related]
15. Isoprenyl carboxyl methyltransferase inhibitors: a brief review including recent patents.
Yang WS; Yeo SG; Yang S; Kim KH; Yoo BC; Cho JY
Amino Acids; 2017 Sep; 49(9):1469-1485. PubMed ID: 28631011
[TBL] [Abstract][Full Text] [Related]
16. A novel Smac mimetic APG-1387 demonstrates potent antitumor activity in nasopharyngeal carcinoma cells by inducing apoptosis.
Li N; Feng L; Han HQ; Yuan J; Qi XK; Lian YF; Kuang BH; Zhang YC; Deng CC; Zhang HJ; Yao YY; Xu M; He GP; Zhao BC; Gao L; Feng QS; Chen LZ; Yang L; Yang D; Zeng YX
Cancer Lett; 2016 Oct; 381(1):14-22. PubMed ID: 27424523
[TBL] [Abstract][Full Text] [Related]
17. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
18. Neferine sensitized Taxol-resistant nasopharygeal carcinoma to Taxol by inhibiting EMT via downregulating miR-130b-5p.
Wang X; Wang K; Xiao J; Song Y; Li H
Biochem Biophys Res Commun; 2020 Oct; 531(4):573-580. PubMed ID: 32811645
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
[TBL] [Abstract][Full Text] [Related]
20. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
